An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
Author:
Funder
China Postdoctoral Science Foundation
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference37 articles.
1. Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy;Saito;Surg Today.,2018
2. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma;Xu;Eur Rev Med Pharmacol Sci.,2018
3. MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma;Yang;J Cell Biochem.,2018
4. Adjuvant therapy in non-small cell lung cancer: current and future directions;Sangha;Oncologist.,2010
5. Gene-expression profiles predict survival of patients with lung adenocarcinoma;Beer;Nat Med.,2002
Cited by 117 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of neutrophil extracellular trap-related biomarkers in non-alcoholic fatty liver disease through machine learning and single-cell analysis;Scientific Reports;2024-09-10
2. IRF9 and STAT1 as biomarkers involved in T-cell immunity in atherosclerosis;Journal of Biosciences;2024-09-02
3. Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer;Heliyon;2024-09
4. Identification of key differentially expressed immune related genes in patients with persistent atrial fibrillation: an integrated bioinformation analysis;BMC Cardiovascular Disorders;2024-07-08
5. High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC);Journal for ImmunoTherapy of Cancer;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3